Market News Top 10 News Biocon Biologics Receives Rs 1,125 crore Capital Investment from Goldman Sachs – Top Indian Market News Biocon Biologics receives Rs 1,125 crore capital investment from Goldman Sachs Biocon Ltd. announced that its subsidiary, Biocon Biologics, has approved a capital injection of Rs 1,125 crore from Goldman Sachs. As per the agreement, Goldman Sachs will be issued Optionally Convertible Debentures at a post-money equity valuation of $3.94 billion (~Rs 26,633 crore). The […] Written by marketfeed Team November 7, 2020April 21, 2022